Search results for Aducanumab
Aducanumab Biosimilar – Anti-APP Abeta mAb – Research Grade, ProteoGenix, PX-TA1335
Description of Aducanumab Biosimilar - Anti-APP Abeta mAb - Research Grade General information on Anti-APP Abeta[Homo sapiens] (Aducanumab) Monoclonal Antibody Aducanumab has been investigated for the treatment of Alzheimer’s Disease.
Host
Reactivity
Applications
Conjugation
Aducanumab, Abbexa, abx831294
Aducanumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting APP Abeta, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Aducanumab has been used in trials studying the treatment of Alzheimer's Disease.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Aducanumab Biosimilar - Research Grade, ichor.bio, ICH5008
Detects human Beta Amyloid. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Aducanumab.
Host
CHO cells
Reactivity
Human
Applications
Conjugation
Research Grade Aducanumab (HY235046), abinScience, HY235046
Host
Human
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
.png "Click to View APP (Aducanumab Biosimilar) Human Monoclonal Antibody#59870 Product Detail")
APP (Aducanumab Biosimilar) Human Monoclonal Antibody#59870, Cell Signaling Technology (CST), 59870
APP (Aducanumab Biosimilar) Human Monoclonal Antibody was confirmed to bind to its intended target aggregated Aβ using bio-layer interferometry.
Host
Human
Reactivity
Human
Applications
Conjugation
Please provide the required information below so that we can quickly source your products.